Mielóma multiplex: vizsgálatok itt: Litvánia
1 of 2 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 2/3. fázisFut, nem toborozThe Relapse from MRD Negativity As Indication for Treatment (REMNANT) Study
- Where
- Vilnius
- Életkor
- 18 év to 75 év
- People
- 176 worldwide
- Run by
- Oslo University Hospital
See details and how to joinNCT04513639 · EU 2023-510215-18-00